Ibrance Capsule
Product Images NDC 0069-0189

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ibrance (NDC 0069-0189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ibrance 01)

Chemical structure diagram of palbociclib, the active ingredient in Ibrance capsules. The structure shows the arrangement of aromatic rings, nitrogen atoms, and other chemical groups characteristic of palbociclib.*

FDA Label Image

Figure 1 (Ibrance 02)

A Kaplan-Meier survival curve graph showing progression-free survival probability (%) on the y-axis versus time in months on the x-axis. Two curves compare treatment with palbociclib plus letrozole (solid line) versus placebo plus letrozole (dashed line). Below the graph, patient counts at risk for each group are displayed over time intervals.*

FDA Label Image

Figure 2 (Ibrance 03)

A Kaplan-Meier curve illustrating progression-free survival probability over time (months) in patients treated with palbociclib plus fulvestrant versus placebo plus fulvestrant. The graph includes a legend and a table indicating the number of patients at risk at various time points for both treatment groups.*

FDA Label Image

Logo (Ibrance 04)

Kaplan-Meier survival curve comparing overall survival probability (%) over time in months for two patient groups: one receiving palbociclib plus fulvestrant and the other receiving placebo plus fulvestrant. The graph includes a legend and a table of the number of patients at risk at various time points for each group.*

FDA Label Image

Principal Display Panel (75 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (125 mg Capsule Bottle Label)

Ibrance 75 mg capsules packaging label by Pfizer Laboratories Div Pfizer Inc. The label shows the product name, active ingredient palbociclib, strength of 75 mg, and a count of 21 capsules. Storage instructions recommend 20°C to 25°C with permitted excursions, and the label states the drug is prescription only (Rx only). Distributed by Pfizer Labs Division, made in Ireland.*

FDA Label Image

Ibrance 08

Label for Ibrance (palbociclib) capsules 100 mg, an oral prescription drug by Pfizer Laboratories. The package contains 21 capsules. The label includes storage instructions, dosage note stating each capsule contains 100 mg palbociclib, and identification barcodes, with distribution by Pfizer Labs, made in Ireland.*

FDA Label Image

Ibrance 09

Label for Ibrance (palbociclib) capsules, 125 mg strength, manufactured by Pfizer Laboratories Division of Pfizer Inc. The label shows the product name, strength, dosage form as capsules, and package count of 21 capsules. Storage instructions indicate temperatures between 20°C to 25°C with permitted excursions. The label also includes prescribing info directions, barcode, and origin as Made in Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.